Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nextleaf SolutionsOILFF +1.31% Equity-to-Asset is 0.49 as of Jun. 2026, which is 17% below its 10-year median of 0.59. The stock has 4 warning signs investors should review. Among 1,008 Drug Manufacturers companies, Nextleaf Solutions ranks worse than 64.19% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Nextleaf Solutions's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $2.70 Mil. Nextleaf Solutions's Total Assets for the quarter that ended in Jun. 2026 was $5.51 Mil.
Therefore, Nextleaf Solutions's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.49.
The historical rank and industry rank for Nextleaf Solutions's Equity-to-Asset or its related term are showing as below:
OILFF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.36 Med: 0.59 Max: 1
Current: 0.51
During the past 9 years, the highest Equity to Asset Ratio of Nextleaf Solutions was 1.00. The lowest was 0.36. And the median was 0.59.
OILFF's Equity-to-Asset is ranked worse than 64.19% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs OILFF: 0.51
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Nextleaf Solutions Equity-to-Asset Related Terms
Nextleaf Solutions Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Nextleaf Solutions's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nextleaf Solutions's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nextleaf Solutions Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nextleaf Solutions's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Nextleaf Solutions's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Nextleaf Solutions's Equity to Asset Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nextleaf Solutions (OILFF) has a Equity-to-Asset of 0.49 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Nextleaf Solutions and its competitors. This is 17% below median its historical median of 0.59. Over the past decade, Nextleaf Solutions' Equity-to-Asset has ranged from 0.36 to 1.00. According to the industry distribution chart, Nextleaf Solutions ranks #647 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 64.2%.
Is Nextleaf Solutions' Equity-to-Asset too high?
Nextleaf Solutions' current Equity-to-Asset of 0.49 is 17% below median its 10-year median of 0.59. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 1.00. The Drug Manufacturers industry median Equity-to-Asset is 0.60. Nextleaf Solutions' value of 0.49 is 18.3% below this industry median. Based on the distribution chart, Nextleaf Solutions ranks #647 out of 1008 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Nextleaf Solutions' Equity-to-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Nextleaf Solutions ranks #647 out of 1008 companies for Equity-to-Asset. This places Nextleaf Solutions in the lower half of its industry. The industry median Equity-to-Asset is 0.60. Nextleaf Solutions' value of 0.49 is 18.3% below this benchmark. Historically, Nextleaf Solutions' own Equity-to-Asset has ranged from 0.36 to 1.00 over the past decade. While the company's 10-year median is 0.59 vs. the industry median of 0.60, Nextleaf Solutions has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nextleaf Solutions's current Equity-to-Asset of 0.49 is 18.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Nextleaf Solutions and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nextleaf Solutions's current Equity-to-Asset is 0.49, which is 17% below median its own 10-year median of 0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nextleaf Solutions stock overvalued right now?
Based on GuruFocus' analysis, Nextleaf Solutions (OILFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.04, compared to a current price of $0.03 — trading 32.5% below its estimated fair value. The current Equity-to-Asset is 0.49, which is 17% below median its 10-year median of 0.59 and 18.3% below the Drug Manufacturers industry median of 0.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Nextleaf Solutions (OILFF), the current Equity-to-Asset is 0.49 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nextleaf Solutions Ltd is is a Canadian cannabis extractor and processor, with a focus on developing intellectual property for the extraction, distillation formulation, and delivery of cannabinoids. The Company has a single reportable segment being the provision of goods and services to the cannabis industry in Canada. All the Company's revenues are generated in Canada. Revenue from sale of goods and services includes sales of bulk distillate, branded (Glacial Gold) vape pens, oils, and softgels (branded extract products), and private label which includes toll processing and other services. Majority being from Branded extract products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OILFF has been successfully added to your 
